We are live on ! Find out more
RC

Renaissance Capital Portfolio holdings

AUM $138M
1-Year Est. Return 39.59%
This Fund
S&P 500
This Quarter Est. Return
+16.17%
1 Year Est. Return
+39.59%
3 Year Est. Return
+247.63%
5 Year Est. Return
+187.28%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$40.8M
Cap. Flow
+$23.1M
Cap. Flow %
13.13%
Top 10 Hldgs %
54.18%
Holding
90
New
2
Increased
69
Reduced
3
Closed
15

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$5.05M
2
RBLX icon
Roblox
RBLX
+$2.42M
3
DASH icon
DoorDash
DASH
+$2.38M
4
KVUE icon
Kenvue
KVUE
+$2.05M
5
ACI icon
Albertsons Companies
ACI
+$1.81M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$4.46M
2
GTM
ZoomInfo Technologies
GTM
+$2.26M
3
OSH
Oak Street Health, Inc.
OSH
+$1.5M
4
FOUR icon
Shift4
FOUR
+$1.27M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.23M

Sector Composition

Rank Sector Weight
1 Technology 37.53%
2 Consumer Discretionary 31.82%
3 Financials 12%
4 Communication Services 8.81%
5 Consumer Staples 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABCL icon
76
AbCellera Biologics
ABCL
$1.71B
– –
-7,957
Closed -$60K
ACDC icon
77
ProFrac Holding
ACDC
$729M
– –
-7,435
Closed -$94.2K
AZEK
78
DELISTED
The AZEK Co
AZEK
– –
-36,949
Closed -$870K
FOUR icon
79
Shift4
FOUR
$4.19B
– –
-16,782
Closed -$1.27M
HRMY icon
80
Harmony Biosciences
HRMY
$2.02B
– –
-8,622
Closed -$282K
LEGN icon
81
Legend Biotech
LEGN
$3.58B
– –
-18,300
Closed -$882K
OLPX
82
DELISTED
Olaplex Holdings
OLPX
– –
-40,708
Closed -$174K
PCVX icon
83
Vaxcyte
PCVX
$7.87B
– –
-23,688
Closed -$888K
RPRX icon
84
Royalty Pharma
RPRX
$26B
– –
-123,913
Closed -$4.46M
GTM
85
ZoomInfo Technologies
GTM
$970M
– –
-91,506
Closed -$2.26M
ZIM icon
86
ZIM Integrated Shipping Services
ZIM
$3.02B
– –
-27,197
Closed -$641K
NARI
87
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-15,943
Closed -$984K
XM
88
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
– –
-42,325
Closed -$755K
RXDX
89
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-11,503
Closed -$1.23M
OSH
90
DELISTED
Oak Street Health, Inc.
OSH
– –
-38,752
Closed -$1.5M
1 2 3
4

Similar funds

LDNAM
Lepercq De Neuflize Asset Management New York $138M AUM 15.9% 1-Year Est. Return
PF
PlanWiser Financial Colorado Springs, Colorado $138M AUM 16.05% 1-Year Est. Return
DW
Durante & Waters Brewster, New York $138M AUM 14.3% 1-Year Est. Return
FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
TC
Tannin Capital Charlotte, North Carolina $138M AUM
PBRA
Pine Brook Road Advisors Bedford, New York $138M AUM 19.16% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Renaissance Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Capital held 90 positions worth $176M, up 30% from $135M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Renaissance Capital deployed $23.1M of net new capital in Q2 2023, opening 2 new positions and adding to 69 existing holdings. Its largest new stake was Kenvue: 78,513 shares worth $2.07M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was XPeng, an estimated $892K trimmed.

  • Renaissance Capital's largest Q2 2023 buy was Kenvue: 78,513 shares worth $2.07M.
  • Renaissance Capital added most to Airbnb in Q2 2023, an estimated $5.05M increase.
  • Renaissance Capital's biggest Q2 2023 reduction was XPeng, cutting an estimated $892K.
  • Renaissance Capital fully exited Royalty Pharma in Q2 2023, selling an estimated $4.46M.
  • Renaissance Capital's ten largest holdings make up 54% of its $176M portfolio in Q2 2023.
  • Renaissance Capital opened 2 new positions and closed 15 in Q2 2023.
  • Renaissance Capital's portfolio value rose 30% quarter-over-quarter to $176M.

Based on Renaissance Capital's 13F filing for Q2 2023, filed 17 Jul 2023.